biotech, I can guarantee you that I am not short. I have stated multiple times on this board that I have been here for 9 years and own over 250K shares. The small wins like Singapore and the $1.5M mean nothing when you have a management team that can't execute. We see statistics like 68 countries, but where is the volume from 68 countries? At this point, I don't care if they add China and Japan. Tout the number of countries as much as you want. If you can't get sales from these countries...it's meaningless to tout.
They spent years trying to learn how to put a company together. I told Dr. Chan from day 1 that he needed to hire a qualified team that has built successful companies. He chose not to do this. The jury is still out on the most recent hires. Make me a believer Dr. Chan.
How many delayed/failed trials does this company have to go through. Do you realize the amount of money this company has burned through over the years because of faulty trials due to incompetence? Even if they get the IDE approved, we are still 2 years away from rolling this out. Revenue just doesn't pop up over night either. So now are you talking about 3-4 years. In the meantime, they just signed a lease to expand production. Why so soon? I would have waited another 6-12 months at a minimum. They are also hiring sales people during a pandemic. Why? They can't get into hospitals...so why bring on additional personnel?
You may ask why I'm still here. That's a good question. I ask that to myself every day. I do have a much lower target that I'm willing to see at now. Years ago I thought we would be at $20-$30. Now, I'm hoping we can get back to $11-$13 over the next year.
So you ask why we don't celebrate the positives? Hope this answers your question.
